The full-length genomes of two DENV-1 viruses isolated during the 2005-2006 dengue incidents in Brunei were sequenced. Twenty five primer sets were designed to amplify contiguous overlapping fragments of approximately 500-600 base pairs spanning the entire sequence of the genome. The amplified PCR products were sent to a commercial laboratory for sequencing and the nucleotides and the deduced amino acids were determined. Sequence analysis of the envelope gene at the nucleotide and amino acid levels between the two isolates showed 92 and 96 % identity, respectively. Comparison of the envelope gene sequences with 68 other DENV-1 viruses of known genotypes placed the two isolates into two different genotypic groups. Isolate DS06/210505 belongs to genotype V together with some of the recent isolates from India (2003) and older isolates from Singapore (1990) and Burma (1976), while isolate DS212/110306 was clustered in genotype IV with the prototype Nauru strain (1974) and with some of the recent isolates from Indonesia (2004) and the Philippines (2002, 2001). In the full-length genome analysis at the nucleotide level, isolate DS06/210505 showed 94 % identity to the French Guyana strain (1989) in genotype V while isolate DS212/110306 had 96 % identity to the Nauru Island strain (1974) in genotype IV. This work constitutes the first complete genetic characterization of not only Brunei DENV-1 virus isolates, but also the first strain from Borneo Island. This study was the first to report the isolation of dengue virus in the country.
INTRODUCTION
Globally, dengue infection has caused many countries, especially in the tropics and subtropical regions, considerable economic burden from loss of working hours due to hospitalization. The common mild infection, dengue fever (DF), is an ancient disease with a history that dates back 200 years. The first global distribution of the severe form, dengue haemorrhagic fever (DHF), occurred after the Second World War, causing epidemics affecting millions of people. The causative agent of dengue is a virus belonging to the flavivirus family. It has been for many decades responsible for the most important mosquito-borne viral disease in humans in terms of morbidity and mortality. The main vectors responsible for human to human transmission are mosquitoes of the Aedes family. Currently, Aedes aegypti and Aedes albopictus have been implicated in causing transmission in urban and suburban areas. To date, the dengue toll has exceeded 100 million new DF cases annually, culminating in the high risk regions of the world, particularly in south-east Asia, the western Pacific and the Americas with population reaching 3 billion in more than 100 countries. From this figure, 500 000 have progressed to DHF, causing up to 25 000 deaths (Gubler & Clark, 1995; Monath & Heinz, 1996; WHO, 1997; Gibbons & Vaughn, 2002) . The explosive growth of the world's population, failed urban infrastructure, inadequate mosquito control measures during the late 20th century, increased air travel and global warming have contributed significantly to the current increase of both deaths and hospitalization from dengue infection (Monath, 1994; Gubler, 1998a, b; WHO, 2002) . Dengue virus comprises four genetically and antigenically distinct serotypes (DENV-1 to . Infection with any of the four serotypes induces life-long protective immunity to the homologous serotype, but confers only transient or no cross-reactive immunity to subsequent infections by the other three serotypes. Clinical manifestations range from a mild, self-limiting illness DF to the more severe form DHF and dengue shock syndrome (DSS) . The factors that determine the disease progression to the more severe form remain elusive as they involve multi-facet interactions between the virus and the host. The manifestations of DHF and DSS are more frequently seen in patients experiencing subsequent dengue infection, suggesting that sub-neutralizing heterotypic dengue virus antibodies are a risk factor for progressing to DHF and DSS in secondary infections (Halstead, 1988; Kurane & Ennis, 1997) . Studies conducted among children with dengue in Thailand reported that bleeding, secondary infection and haemoconcentration of .22 % from baseline haematocrit are the risk factors for developing to DSS (Tantracheewathorn & Tantracheewathorn, 2007) , while other studies have shown the association of distinct genotypes with differences in virus virulence following reports of primary infections resulting in DHF/DSS (Rosen, 1977) . It has been reported that certain genotypes such as Asian DENV-2 have been more often associated with DHF/DSS (Rico-Hesse et al., 1997; Gubler, 1998a; Leitmeyer et al., 1999) .
The dengue viral genome is a~11 kb, single-stranded (+) RNA, coding for a polyprotein of~3400 aa which is coand post-translationally cleaved at the rough endoplasmic reticulum by a combination of cellular and viral proteases into three structural (C, prM and E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) . The single open reading frame is preceded bỹ 100 nt of 59 untranslated region (UTR) and tailed bỹ 400 nt of the 39 UTR. The 59 end of the viral genome is capped with type I 7-methyl guanosine structure, while the 39 end is not polyadenylated (Lindenbach & Rice, 2001; Bartenschlager & Miller, 2008) . Many investigators have made comparative analyses of nucleotide and amino acid sequences of short segments of specific gene regions to study molecular epidemiology and evolution of the dengue virus strains by characterizing them into genotypes (Rico-Hesse, 1990; Blok et al., 1991; Deubel et al., 1993; Lewis et al., 1993; Lanciotti et al., 1994; Chungue et al., 1995) . Consequently, genotypic characterization has been useful in monitoring the eventual appearance of genetic changes in dengue viruses, identifying the circulating serotype in an area and detecting the introduction of new genotypes. In earlier studies, molecular analyses of DENV-1 were based on either a fragment in the 59 end of the envelope (E) gene (Chungue et al., 1995) or a 240 bp region of the E-NS1 gene junction (Rico-Hesse, 1990), generating three to five different genotypes. In the Americas, it was found that one or two genotypes of DENV-1 were maintained at an endemic level causing the classical DF and occasional sporadic DHF. Later, whole envelope gene analysis of 44 DENV-1 strains from all regions of the world further revealed the existence of five genotypes (Goncalvez et al., 2002) . Other E gene analysis also supported these genotypic groupings (Laille & Rochie, 2004) . Neutralizing epitopes of the E gene have been localized at two sites, Asn-67 and Asn-153, with N-linked glycosylation potential. Changes to these sites may affect virus-mediated membrane fusion and neurovirulence (Anderson et al., 1992; Chen et al., 1996) Although surrounded by countries known to be endemic or hyperendemic for dengue, the disease is not a major public health problem in Brunei, as there has been no report of deaths due to dengue virus infections. However, serological data from the Public Health Department, Ministry of Health, Brunei, indicated that from 1992 to 2006 a considerable number of patients suspected of dengue infection with dengue classical symptoms had IgM antibodies. This indicates that the virus had infected the patients and was in fact circulating in the country. Brunei is situated on the island of Borneo in south-east Asia with her close neighbours, the Malaysian states of Sabah in the east and Sarawak in the west. With a total area of a mere 5765 km 2 , half of the country's population of 383 000 lives in the capital, Bandar Seri Begawan. Three quarters of the country is still covered with thick tropical rainforest and has an annual rainfall of 2540 mm. These humid and wet weather conditions together with poor infrastructure make it a favourable breeding ground for Ae. aegypti and Ae. albopictus. Furthermore, the yearly reports of deaths due to dengue in the neighbouring Malaysian states of Sabah and Sarawak have intensified the importance of this infection as movement of humans between Brunei and these countries could increase the risk of infection with more virulent strains. The lack of tissue culture and molecular laboratory facilities in the country has hampered the effort of isolating and typing the virus. , 2006) ]. Taking into account the current increase in air and land human travel between these countries, it is anticipated that outbreaks may be on the rise, which may increase the risk of DHF. It is well known that infected human travellers can introduce new serotypes or variants in a country or region. Our previous study showed that the predominant serotype infecting the population in Brunei in 2005-2006 was DENV-2, followed by DENV-1 (Osman et al., 2007) . This study aimed to characterize at the molecular level the DENV-1 virus isolated during the 2005-2006 dengue incidents and determine any significant differences between the isolates.
METHODS
Sample recruitment. A total of 719 serum samples were collected from patients suspected of dengue infection over a period of one year from April 2005 until April 2006. The samples were collected from clinics and hospitals in Brunei and hence covered the whole populated area of the country. Earlier, the samples were tested for dengue IgM and IgG antibodies using the commercial rapid test Panbio strip kit in the Department of Laboratory Services, Ministry of Health, Brunei, where they were stored at 220 uC. The samples were then transported to the Department of Medical Microbiology, University of Malaya, Kuala Lumpur, Malaysia, where further dengue confirmatory tests were carried out. Dengue RT-PCR (Kong et al., 2006) , in-house IgM capture ELISA (Lam et al., 1987) , NS1 antigen detection (Young et al., 2000; Alcon et al., 2002; Libraty et al., 2002) and virus culture in the C6/36 mosquito cell line were employed.
Virus isolation and serotyping. The DENV-1 strains used were isolated in 2005-2006 from suspected dengue cases in the country. The viruses were cultured in the Ae. albopictus clone C6/36 mosquito cell line (Igarashi et al., 1982) . The C6/36 monolayer was grown in a IP: 54.70.40.11
On: Mon, 22 Jul 2019 17:49:15 25 cm 3 angle-neck tissue culture flask and inoculated with 100 ml patient's serum or infected cell culture supernatant and kept at 37 uC for 1 h to allow for virus adsorption. The infected fluid was harvested after 10 days incubation at 28 uC. All isolates were cultured up to three passages before PCR amplification and sequencing. The growth was monitored by the indirect immunofluorescence antibody test (IFAT) using dengue-specific monoclonal antibodies [DEN 1 (MAB D2-1F1-3), DEN 2 (MAB 3H2-1-21), DEN 3 (MAB D6-8A1-12) and DEN 4 (MAB 1410-6-7)] (kindly provided by the Centers for Disease Control and Prevention, Fort Collins, CO, USA) to detect the antigen in fixed infected cells. The presence and typing of virus in tissue culture supernatants were further confirmed by a one-step real-time RT-PCR amplification protocol (Kong et al., 2006) which was carried out using the QuantiTect SYBR Green RT-PCR reagent kit (Qiagen). The amplification process was carried out in a Bio-Rad iCycler system. Five microlitres of the extracted RNA was assayed in a 25 ml reaction mixture. The thermal profile consisted of a reverse transcription step at 50 uC for 30 min, Taq polymerase activation at 95 uC for 10 min, followed by 35 cycles at 94 uC for 30 s (denaturation), 60 uC for 40 s (annealing) and 72 uC for 50 s (extension). The two Brunei DENV-1 isolates used for the study were designated DS06/210505, isolated in 2005, and DS212/110306, isolated in 2006.
Primer design. A total of 25 synthetic oligonucleotide primer pairs were designed to amplify overlapping fragments of sizes between 500 and 600 bp spanning the whole genome of DENV-1 viral RNA. The primer sequences were based on the full-length sequence of Singapore DENV-1 strain S275/90 (GenBank accession no. M87512). The sequences of the oligonucleotide primer pairs used in the study are available in Supplementary Table S1 (available in JGV Online).
RNA extraction and cDNA synthesis for amplification and sequencing. Viral RNA was extracted from the supernatant of infected cells using a QIAamp Viral RNA mini kit (Qiagen) according to the manufacturer's instructions. cDNA synthesis and PCR of the target sequence were carried out using a commercial kit, AccessQuick RT-PCR System (Promega). The amplification process was carried out using the in-house protocol parameters as follows in the PTC-200 Peltier thermal cycler: 40 cycles of denaturation at 94 uC (30 s), primer annealing at 55 uC (45 s), primer extension at 72 uC (1 min) and final extension at 72 uC (5 min). Gel electrophoresis was used to confirm the size of the target PCR product. The PCR product was purified using a QIAquick PCR purification kit (Qiagen). The risk of error incurred as a result of using Taq DNA polymerase is significantly minimized as the PCR products generated by using 25 sets of primers were of 500-600 bp. Purified PCR products of less than 1 kbp are known to be stable and therefore can be used for direct sequencing.
DNA sequencing of PCR products. DNA sequencing of the PCR products was carried out by a commercial laboratory (Macrogen) using the Sanger dideoxy sequencing method (Sanger et al., 1977) .
Nucleotide sequences used in the study. For the whole envelope gene analysis, 70 DENV-1 E gene sequences were used, retrieved from the National Center for Biotechnology Information (NCBI) GenBank database (http://www.ncbi.nlm.nih.gov/), with the accession numbers listed in Table 2 . For the whole genome analysis, 20 DENV-1 full genomes were used. Sequences of DENV-2, DENV-3 and DENV-4 were used for rooting the phylogenetic tree.
Sequence and phylogenetic analysis. Multiple sequence alignments were performed using the CLUSTAL W program (http:// www.ebi.ac.uk/clustalw/). Phylogenetic analyses were conducted using the MEGA4 program (Tamura et al., 2007) . Phylogenetic trees were constructed from aligned nucleotide sequences using neighbourjoining and maximum-parsimony methods using maximum composite likelihood for DNA substitution test. Fig. 2 shows the phylogeny tree based on the DENV-1 envelope gene sequence. The tree that represents comparison between DENV-1 whole genome sequences is presented in Fig. 3 . Branch topology was verified by generating 1000 bootstraps.
RESULTS
Of the 719 serum samples studied, 71 (9.87 %) were dengue capture IgM ELISA positive and 16 (2.22 %) had viral RNA detected in their blood. Dengue RT-PCR and IFAT identified 13 DENV-2 and 3 DENV-1. Two of the Brunei DEN-1 viruses were full-length sequenced, the third isolate failed to grow in cell culture. The sequences were deposited in GenBank with accession nos EU179860 and EU179861 for isolates DS06/210505 and DS212/110306, respectively. Pair-wise nucleotide sequence alignment spanning the envelope (E) gene of the two Brunei strains showed an identity of 92 % and a divergence of 7.6 %, reflecting a total of 113 nt changes between them (Fig. 1) . The changes were randomly scattered throughout the gene without a particular region of hypervariability. Between the two isolates, 95 changes were located at the third position of the codon, therefore rendering them silent mutations at the amino acid level. The remaining 18 nt changes, of which 15 were located in the first position and 3 in the second position of the codon, resulted in 16 aa changes (Table 1) Multiple sequence alignment of the E gene incorporating 70 DENV-1 strains showed that isolate DS06/210505 had a 96 and 98 % identity at the nucleotide and amino acid levels, respectively, with Burma strain PRS 228686 (isolated in 1976) in the genotypic group V ( Table 2 ). The identity with the Singapore strain was 94 and 98 %, while with the Indian strains isolated in 2003, the identity was 94 and 97 %, respectively (Table 2) . However, isolate DS212/ 110306 had an identity of 97 and 98 % at the nucleotide and amino acid level, respectively, with the Indonesia strain SC01 (isolated in 2004), placing it in the genotype IV (Table 2) of the DENV-1 classification (Goncalvez et al., 2002; Ong et al., 2008) . The identity with the Philippines strains isolated in 2002, 2001 and 1999 in the same genotype was 96 and 98 % at the nucleotide and amino acid level, respectively ( Table 2) . The E gene of the Brunei DENV-1 isolates has a deletion of three nucleotides from positions 1045 to 1047. All the other 68 DENV-1 strains used had E gene sequences of 1485 nt. The percentage divergence at the nucleotide level between all the DENV-1 envelope gene sequences used ranged from 0.2 to 10.3 %. The phylogenetic analysis of the whole genome sequence has also classified the two Brunei DENV-1 isolates into the same genotypic groupings. The sequences were compared with 20 other DENV-1 full-length genomes (Ong et al., 2008) . In previous studies, five genotypes were observed using the 6 % cut-off value as the maximum genetic distance within a given genotypic group or subgroup when the whole envelope gene of 31 DENV-1 strains worldwide was analysed (Rico-Hesse, 1990) . Other studies that follow also confirmed this genotypic grouping (Goncalvez et al., 2002; Laille & Rochie, 2004; Domingo et al., 2006; Ong et al., 2008) .
The 16 aa changes (Table 1) in the envelope gene between the two Brunei strains include the non-conservative substitutions at positions 37 (domain I), 379 (domain III) and 439 (transmembrane region) which was also shown in the E gene analysis of two DENV-1 isolates from French Polynesia (Laille & Rochie, 2004) . The other nonconservative changes found among Brunei strains were at positions 128 (domain I) and 436 (transmembrane region). They also share conservative changes at positions 88, 114 (domain I) and 369 (domain III) reported in the study (Laille & Rochie, 2004) . In addition, other conservative changes recognized were at positions 77, 96, 161 (domain I) and 312, 340, 359, 364, 377 (domain III) (Table 1 ). As indicated from previous studies, predominant changes of the amino acids in the E protein may be due to virus adaptation in tissue culture (Lee et al., 1997) Phylogenetic analyses based on the E gene and the full-length genomes were conducted using the MEGA4 software. For the E gene, 70 DENV-1 strains were uploaded in the program together with 3 other dengue virus serotypes (DENV-2, DENV-3 and DENV-4) as outgroups, while 20 DENV-1 strains were used in the full-length genome analysis. Full genome sequences of DENV-2, DENV-3 and DENV-4 were used to root the tree. Phylogenetic trees were built using neighbour-joining (NJ) and maximum-parsimony (MP) methodologies, but only MP trees of higher bootstrap values and desired topology were used. The phylogeny was constructed using the maximum composite likelihood as the parameter for the DNA substitution and bootstrapped with 1000 replicates. Five genotypes were observed for DENV-1 from the E gene analysis (Fig. 2) but, due to the lack of fulllength genome sequences representing genotype III in the GenBank database, the tree for the full-length sequence analysis only showed four genotypic groupings (Fig. 3 ). All trees were rooted using DENV-2, DENV-3 and DENV-4 as outgroups.
DISCUSSION
The serological data have indicated that dengue virus is circulating in the country; furthermore, since Brunei is surrounded by countries experiencing an increasing incidence of the severe form of the disease, the importance of this study becomes more prominent, as it will provide useful information regarding the distribution of dengue virus in the country and in the region so appropriate measures by the public health authority can be put in place. Phylogenetic analyses group viruses into their respective subtype based on the percentage identity and divergence between paired nucleotide and deduced amino acid sequences. The main objective of the study is to characterize DENV-1 viruses isolated in Brunei. So far, Brunei has experienced dengue infection throughout the year, peaking during the rainy season; however, there have not been reports of deaths from dengue. diverge by 4.1 %. Isolate DS212/110306 also diverged by 2.3 % from its common ancestor shared with the Indonesian strain (isolated in 2004). However, the inclusion of more sequences from recent years from nearby neighbouring countries would give further information to narrow the source of the virus origin. At the envelope protein level, for isolate DS06/210505, the substitutions at sites 54 (SAA) and 77 (QAP) and the deletion at location 349 would make that protein region hydrophobic. Changes at sites 96 (FAL), 297 (MAV), 312 (VAM) and 349 (deletion) have no effect on the protein, while amino acid substitutions at positions 364 (PAS) and 442 (AAT) would cause it to be hydrophilic. In the case of isolate DS212/110306, changes at the sites 52 (DAN), 128 (KAN), 339 (SAT) and 340 (QAK) have no effect on the hydrophobicity, but only some charge reversal properties. The substitution of threonine to isoleucine at position 359 (TAI) and the deletion at position 349 have made that part of the envelope hydrophobic. It is not known what effect these changes have on the function of this protein. The important biological functions of viral attachment to a specific cell-surface receptor and membrane fusion are performed by the E glycoprotein, which is also a target and a modulator of the host immune response, and is located on the surface of dengue viruses (Heinz & Roehrig, 1990; Anderson et al., 1992; Chen et al., 1996) .
Currently we are working to investigate the biological characteristics of these isolates and to correlate the changes to the biology of the Brunei isolates. Due to the lack of nucleotide sequences in the GenBank database representing either the E gene region or the whole genome of the dengue virus from the nearest neighbouring countries, the precise origin of the virus infecting the population of Brunei cannot be determined; however, this study has generated some valuable data at the genetic level which can be used as a preliminary source for current and future molecular epidemiology of dengue virus in Brunei, as well as for monitoring the introduction of potential virulent strains.
